However, injection of GCSF following CYT treatment (THROUGH) and after CYT treatment (AFTER) extended mice life from 6.5 weeks (without GCSF; AML + CYT) to 7 and 7.5 weeks, respectively (Figure 2A). Here, CSF3 is linked to acute myeloid leukemia.